Driving under the influence (DUI) of psychoactive substances is an issue of paramount concern in both public health and the criminal justice system. It affects millions of Americans yearly, and while there is extensive research on DUI among...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
The purpose of this resource guide is to share an overview of ROSC and illustrate how these systems are an integral part of the new health care environment. This guide will align the tenets of health care reform to the benefits, framework...
Every September the Recovery Month Campaign aims to increase awareness and understanding of mental and substance use disorders and celebrate the people who recover.
Over the years, Recovery Month has promoted and supported new evidence...
The Substance Abuse and Mental Health Services Administration (SAMHSA) National Center of Excellence for Tobacco-Free Recovery Grant is now open for applications. Offering up to 5 million USD the grant can be used for a range of projects...
